Sun Pharmaceutical Industries has target of Rs 1600, says Technical Analyst, Ashwani Gujral.

Gujral told "Clearly the largecap and midcap pharmaceutical is doing well. So for Sun Pharmaceutical Industries the next target could be Rs 1,600 and for Ranbaxy Laboratories level of Rs 520 is possible.”..

Dr Reddy’s Laboratories (DRL), India’s third-largest pharma company, has seen a sharp rise of 25% in its stock price over the past fifteen
trading sessions. The company’s stock price has vaulted on rumours of a possible promoter stake sale of 5% to GlaxoSmithKline (GSK), one of the world’s top phar..

SHARES of Dr Reddy’s Laboratories (DRL) climbed to a 52-week high of Rs 851.55 on Thursday on speculation that a leading global pharma firm is in talks with the promoters to buy a substantial stake in the company at a premium to the existing share price.

The scrip of the country’s second-largest ..